Acute phase mediator interleukin-6 and depression, work-related stress among young people (25-44 years old)

QR Code

Acute phase mediator interleukin-6 and depression, work-related stress among young people (25-44 years old)

Aim. To study the association of interleukin-6 (IL-6) levels with depression and stress at work among young people (25-44 years old) in Novosibirsk.Material and methods. A random representative sample of young people (25-44 years old) in Novosibirsk was surveyed (975 people of both sexes; response r...

Full description

Saved in:

Bibliographic Details
Main Authors:	V. V. Gafarov, E. A. Gromova, E. V. Kashtanova, I. V. Gagulin, Y. V. Polonskaya, A. V. Gafarova, Yu. I. Ragino
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2024-03-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	interleukin-6 depression workplace stress young people
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/3767
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Psychosocial risk factors for cardiovascular disease: vital exhaustion and its associations with biochemical markers of inflammation among persons 25-44 years old
by: V. V. Gafarov, et al.
Published: (2024-03-01)

MYOCARDIAL INFARCTION AND STROKE: 16-YEAR RISK AND STRESS AT WORK IN OPEN POPULATION OF 25–64-YEAR-OLD WOMEN IN RUSSIA/SIBERIA (WHO MONICA–PSYCHOSOCIAL PROGRAM)
by: V. Gafarov, et al.
Published: (2016-04-01)

Adipokines and personal anxiety in individuals aged 25-44 years
by: V. V. Gafarov, et al.
Published: (2025-07-01)

Depression as an independent risk factor for cardiovascular diseases and cognitive impairment in people aged 25-44 years
by: V. V. Gafarov, et al.
Published: (2024-06-01)

Cardiometabolic risk factors and their relationship with the interleukin-6 receptor gene polymorphism (rs2228145) in patients with hypertrophic cardiomyopathy
by: T. G. Bezhanishvili, et al.
Published: (2020-11-01)

Detection of interleukin-6 and interleukin-8 in serum from women with recurrent spontaneous abortion
by: Baghdad Science Journal
Published: (2010-09-01)

Interleukin 6 as a pathogenic factor mediating clinical manifestations and a therapeutic target for rheumatic diseases and depressive disorders
by: T. A. Lisitsyna, et al.
Published: (2019-07-01)

The prospects of interleukin-6 inhibition in rheumatoid arthritis: Olokizumab (novel monoclonal antibodies to IL-6)
by: E. L. Nasonov, et al.
Published: (2022-11-01)

Pharmacotherapy of giant cell arteritis and polymyalgia rheumatica: Prospects for the use of monoclonal antibodies to interleukin 6
by: Evgeny L. Nasonov, et al.
Published: (2024-09-01)

Vital exhaustion as a marker of chronic social stress and smoking among people aged 25-44 years
by: V. V. Gafarov, et al.
Published: (2024-04-01)

INNOVATIVE TREATMENTS FOR TAKAYASU’S ARTERITIS: A FOCUS ON INTERLEUKIN-6 INHIBITORS. THE AUTHORS’ EXPERIENCE WITH TOCILIZUMAB AND A REVIEW OF LITERATURE
by: T. V. Beketova, et al.
Published: (2017-10-01)

INTERLEUKIN-6 PROFILE IN EARLY POSTOPERATIVE PERIOD AFTER KIDNEY TRANSPLANTATION
by: A. V. Vatazin, et al.
Published: (2013-03-01)

New areas of the pharmacotherapy of rheumatic diseases are inhibition of interleukin-6 and interleukin-17
by: Evgeny Lvovich Nasonov
Published: (2013-10-01)

INHIBITION OF INTERLEUKIN 6 IN IMMUNE INFLAMMATORY RHEUMATIC DISEASES: ACHIEVEMENTS, PROSPECTS, AND HOPES
by: E. L. Nasonov, et al.
Published: (2018-01-01)

EXPERIENCE WITH TOCILIZUMAB, AN INTERLEUKIN 6 INHIBITOR, USED FOR THE TREATMENT OF GIANT CELL ARTERITIS WITH SEVERE COMORBIDITY
by: T. V. Beketova, et al.
Published: (2018-05-01)

Associations of levels of biochemical markers of chronic and acute inflammation, abdominal obesity and post-COVID syndrome in COVID-19 convalescents
by: A. A. Karaseva, et al.
Published: (2024-11-01)

THE ROLE OF INTERLEUKIN-6 GENE IN DEVELOPMENT OF IDIOPATHIC SICK SINUS SYNDROME
by: S. Yu. Nikulina, et al.
Published: (2016-10-01)

A clinical case of adult-onset Still's disease resistant to therapy with tumor necrosis factor-alpha inhibitors and interleukin-6 inhibitors
by: R. R. Samigullina, et al.
Published: (2019-03-01)

The impact of early peroral feeding on concentration of the serum interleukin–6 in patients after pancreaticoduodenectomy
by: A. V. Skums, et al.
Published: (2020-05-01)

CORRELATION BETWEEN CLINICAL MANIFESTATIONS OF OSTEOARTHRITIS AND FLUCTUATING BLOOD LEVELS OF INTERLEUKIN 6
by: Darya Andreevna Kopylova, et al.
Published: (2012-10-01)

The efficacy and safety of sarilumab, fully human monoclonal antibodies against interleukin 6 receptor, in rheumatoid arthritis: new evidence
by: E. L. Nasonov, et al.
Published: (2019-11-01)

A Systematic Review with Meta-Analysis and Indirect Comparison of the Effectiveness of COVID-19 Anti-Interleukin Therapy
by: Yu. M. Gomon, et al.
Published: (2023-07-01)

The efficacy of interleukin-6 inhibitor tocilizumab for takayasu’s arteritis, after insufficient response to previous treatment with glucocorticoids, methotrexate, cyclophosphamide, fludarabine. (A case report)
by: V. N. Antipova, et al.
Published: (2021-01-01)

IMMUNOPATHOLOGY AND IMMUNOPHARMACOTHERAPY OF CORONAVIRUS DISEASE 2019 (COVID-19): FOCUS ON INTERLEUKIN 6
by: E. L. Nasonov
Published: (2020-06-01)

СHARACTERISTICS OF THE HEART FATTY ACID-BINDING PROTEIN, INTERLEUKIN-6 AND INTERLEUKIN-8 AS ALTERNATIVE MARKERS OF DIABETIC NEPHROPATHY PROGRESSION IN PATIENTS WITH TYPE 1 DIABETES MELLITUS
by: Yu. A. Ryzhikova, et al.
Published: (2015-10-01)

Сomparative characteristics of serum and cerebrospinal interleukin-6 values in patients with serous and purulent meningitis
by: Ya. S. Ulyanova, et al.
Published: (2025-04-01)

Role of interleukin-6 in the development of atherosclerosis in rheumatoid arthritis
by: Elena Vasilyevna Udachkina, et al.
Published: (2013-10-01)

Editorial: Targeting the interleukin-1β/interleukin-6/C-reactive protein pathway in clinical medicine - a road map to clinical trial design
by: Jan Torzewski, et al.
Published: (2025-06-01)

Frequency of Tumor Necrosis Factor-α, Interleukin-6, and Interleukin-10 Gene Polymorphisms in Mexican Patients with Diabetic Retinopathy and Diabetic Kidney Disease
by: Patricia Elvira Sánchez-Valencia, et al.
Published: (2025-04-01)

The dynamics of interleukin-6level in HIV-infected patients with herpes zoster
by: A. L. Yakubenko, et al.
Published: (2015-07-01)

Interleukin-6 in schizophrenia is associated with negative symptoms, side effects of therapy and smoking: results of a pilot study
by: T. V. Zhilyaeva, et al.
Published: (2022-07-01)

Association of metabolic and inflammatory molecule levels and post-covid syndrome of varying severity
by: A. A. Karaseva, et al.
Published: (2025-07-01)

Determination of Interleukins 2, 6 and some liver enzymes in gallstone patients' pre- and post- cholecystectomy
by: Wasan S. Oubied, et al.
Published: (2023-02-01)

Role of myokines in regulation of a power exchange
by: V. I. Scherbakov, et al.
Published: (2012-06-01)

Evaluation of interleukin-6 level in patients with chronic lymphocytic leukemia and its correlation with the stage of the disease
by: Nuha Abd Ali Al-Sarai, et al.
Published: (2025-01-01)

SLEEP DISORDERS AND THE RISK OF ARTERIAL HYPERTENSION AND STROKE IN OPEN FEMALE POPULATION 25-64 YEAR OLD IN RUSSIA/SIBERIA (POPULATIONAL STUDY — WHO PROGRAM “MONICA-PSYCHOSOCIAL”)
by: V. V. Gafarov, et al.
Published: (2017-10-01)

LEVELS OF INTERLEUKINS AND MELATONIN IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: M. A. Shalenkova, et al.
Published: (2014-11-01)

Vital exhaustion and risk development of the stroke in general population men in 25–64 years old (epidemiological investigation of basis program WHO MONICA-psychosocial)
by: V. V. Gafarov, et al.
Published: (2009-02-01)

THE RELATION OF PERSONAL ANXIOUSNESS AND SELF-AWARENESS ABOUT THE HEALTH CONDITION, AND ITS INFLUENCE ON 16-YEAR RISK OF ACUTE CARDIOVASCULAR DISEASES DEVELOPMENT IN WOMEN 25-64 YEARS OLD
by: V. V. Gafarov, et al.
Published: (2014-08-01)

Experience of using the interleukin-6 inhibitor olokizumab in patients with rheumatoid arthritis in real-life clinical practice (based on data from Tyumen Regional Rheumatology Center)
by: I. M. Patrikeeva, et al.
Published: (2025-02-01)